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Introduction: Avian influenza viruses circulate in bird populations, and it is important to maintain and uphold
our knowledge of the viral strains that are currently of interest in this context. Here, we describe the use of
hemagglutinin-pseudotype retroviruses based on highly pathogenic influenza viruses for the screening of avian
sera for influenza A antibodies. Our aim was also to determine whether the pseudovirus neutralization
tests that we assessed were sensitive and simple to use compared to the traditional methods, including
hemagglutination inhibition assays and microneutralization tests.
Material and methods: H5 and H7 pseudovirus neutralization tests were evaluated by using serum from
infected rabbits. Subsequently, the assays were further investigated using a panel of serum samples from avian
species. The panel contained samples that were seropositive for five different hemagglutinin subtypes as well
as influenza A seronegative samples.
Results and discussion: The results suggest that the pseudovirus neutralization test is an alternative to
hemagglutination inhibition assays, as we observed comparable titers to those of both standard microneu-
tralizations assays as well as hemagglutinin inhibition assays. When evaluated by a panel of avian sera, the
method also showed its capability to recognize antibodies directed toward low-pathogenic H5 and H7. Hence,
we conclude that it is possible to use pseudoviruses based on highly pathogenic avian influenza viruses to screen
avian sera for antibodies directed against influenza A subtypes H5 and H7.
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I
nfluenza A virus (IAV) belongs to the family
Orthomyxoviridae, and its genome consists of eight
RNA segments of negative polarity that together code
for a minimum of 10 proteins. Classification of IAV is
based on the two surface proteins hemagglutinin (HA)
and neuraminidase (NA). Studies have previously de-
scribed 16 serologically distinct and well-characterized
types of HA and nine different types of NA in birds (15),
and nearly all of the 144 combinations of these two
proteins were found in wild dabbling ducks (6, 7).
However, in 2009, a novel IAV H17N10 variant was also
discovered in fruit bats (8, 9). IAV is endemic in waterfowl,
especially in species belonging to the order Anseriformes,
and it is particularly prevalent in dabbling ducks of
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the genus Anas, suggesting that this taxon constitutes
the natural reservoir (6, 1012).
Highly pathogenic avian influenza (HPAI) can circu-
late in wild birds, and it can have a deadly outcome if
introduced into domestic poultry (13, 14). Two subtypes
of HPAI virus, designated H5 and H7, have been found
in birds (1517). Furthermore, over the past 10 years,
630 cases of H5N1 HPAI have been confirmed in
humans, 375 of which led to death (18). Recently, avian
influenza of subtype H7N9 has emerged in China, with
132 cases confirmed, 37 of them resulting in death (19).
As of yet, the role of migratory waterfowl as vectors of
HPAI virus has not been proven or disproven (2022).
Although outbreaks of HPAI virus are extremely rare
in wild birds, it is possible that HPAI virus can be
maintained in populations of these avian species (23),
indicating the importance of surveillance.
Low pathogenic avian influenza (LPAI) virus circulates
in wild ducks and is normally not associated with severe
disease. Mallards exhibit immune responses when experi-
mentally infected with LPAI virus (24), whereas it has
been suggested that infections with LPAI virus in wild
birds have only minor clinically measurable effects (25
27). In birds, influenza virus is excreted continuously in
feces for up to 12 days (24, 28), and antibodies to IAV can
be detected long after viral shedding has ceased (7).
Consequently, RT-PCR detection of the shedding of viral
RNA is often performed to monitor the current influenza
status in birds. A method that is used to detect influenza
A antibodies is the hemagglutination inhibition (HI)
assay, and it has long been the preferred method for that
purpose even though it is well known that HI titers can
vary between laboratories (29, 30). As an alternative, HA
subtype-specific enzyme-linked immunosorbent assays
(ELISAs) can be used to screen sera for IAV antibodies.
However, there are no commercially available ELISA kits
specific for all 17 of the known HA subtypes, and, as
with the HI assay, ELISA cannot specifically detect
neutralizing antibodies. Virus neutralization tests, which
are usually performed in microformat (microneutraliza-
tion, or MN) (31), represent another option, but these
methods require the use of viable wild-type virus and
also biosafety level 3 containment facilities when hand-
ling HPAI viruses. Moreover, evaluation of neutralization
tests by cytopathic effect (CPE) is time consuming and
laborious, and titers can vary between laboratories.
MN tests based on pseudoviruses expressing IAV HA
H5 and H7 on the surface have been recognized as reliable
and safe alternatives for detection of IAV-neutralizing
antibodies (3239). Another aspect of using pseudovirus
particles is the fact that it makes collaborations easier,
as sharing plasmids or even viral antigen sequences is
preferable over sending live infectious virus. To further
examine the prospects of pseudovirus particle neutraliza-
tion tests (pp-NTs), we performed and evaluated seven
pp-NTs using different subtypes of HPAI pseudoviruses
(six H5 and one H7) to screen for antibodies against
matching subtypes of LPAI virus. The HPAI variants
are useful because of the elongated polybasic cleavage
site in the HA, which is efficiently cleaved into HA1 and
HA2 by cellular proteases (40, 41). Serum from infected
rabbits was used to enable comparison of the pp-NTs
with the traditional HI assay and with MN tests using
CPE as readout, as well as two additional MN tests based
on enzyme-catalyzed color development. Further, the
pp-NTs were evaluated using a panel of sera obtained
from experimentally and naturally infected avian species.
The results of this study confirm that pseudoviruses based
on HPAI are neutralized by immune serum from both
LPAI-H5- and LPAI-H7-infected animals, and that the
pp-NTs are a good alternative to the traditional methods
used to screen for IAV antibodies in avian sera.
Materials and methods
Viruses and retroviral particles pseudotyped with
HPAI HA
The protocol for inoculation of hens’ eggs was approved
by the Committee on the Ethics of Animal Experiments,
Karolinska Institutet, Stockholm, Sweden (permit num-
ber N341/06). LPAI virus of the strain A/mallard/
Sweden/6566/2004 (H5N2) or A/mallard/Sweden/7206/
2004 (H7N7) (GenBank: JN674638) was inoculated
into the allantoic cavity of 10-day-old embryonated
specific-pathogen-free hens’ eggs. The eggs were then
incubated for 72 h at 378C followed by 1224 h at 48C,
after which the allantoic fluid was harvested, centri-
fuged, and stored at 708C until used. The HA genes
of the H5N2 and H7N7 isolates were sequenced by
Sanger sequencing according to a previously established
protocol (42). The HA pseudotypes were based on the
six H5N1 HPAI strains A/Anhui/1/2005, A/HongKong/
213/03, A/Indonesia/5/2005, A/whooper swan/Mongolia/
244/2005, A/turkey/Turkey/1/2005, and A/Vietnam/1194/
2004, as well as the HPAI H7NI strain A/chicken/Italy/
13474/99; here, these pseudotypes are simply denoted
as Anhui, Hong Kong, Indonesia, Mongolia, Turkey,
Vietnam, and Italy (H7), respectively. Reports in the
literature give detailed descriptions of the cloning of the
full-length HA open reading frame into the expression
vector pI.18, the production of retroviral (MLV) vector
particles pseudotyped with IVA HA (39), and the MLV
gag/pol and firefly luciferase (Luc) reporter MLVLuc
constructs (43, 44).
Cell lines
MadinDarby canine kidney (MDCK) cells (ATCC:
CCL-34) were cultured in Medium 199 supplemented
with 10% fetal bovine serum (FBS), 100 U/mL penicillin,
and 100mg/mL streptomycin. Human kidneyderived 293T/
Sofie Wallerstro¨m et al.
2
(page number not for citation purpose)
Citation: Infection Ecology and Epidemiology 2014, 4: 23011 - http://dx.doi.org/10.3402/iee.v4.23011
17 cells (ATCC: CRL-11268) were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
15% FBS and antibiotics (100 U/mL penicillin and 100
mg/mL streptomycin). The cells were maintained at 378C in
a humidified atmosphere with 5% CO2. All reagents were
purchased from Life Technologies.
Serum samples
Rabbits were immunized with IAV according to a slightly
modified protocol (45). Intranasal infections of rabbits
were carried out in strict accordance with the provisions
and general guidelines of the Swedish Animal Welfare
Agency. The protocol was approved by the Committee on
the Ethics of Animal Experiments at Karolinska Institu-
tet, Stockholm (permit number N386/07), and all efforts
were made to minimize suffering. Two New Zealand
white rabbits were intranasally infected with 1 mL of
egg-grown H5N2 or H7N7 virus per nostril, followed
by a booster dose 3 weeks later. Before infection, serum
samples were collected via an ear vein while the rabbits
were under mild anesthesia (Hypnorm), and the animals
were sampled and euthanized (Hypnorm/Dormicum)
9 weeks after infection. To confirm subtype specificity
of the acquired sera, IAV antibody ELISA (IDEXX
Laboratories Inc.) and H5 and H7 subtype-specific
ELISAs (ID.vet Innovative Diagnostics) were performed
according to the manufacturers’ protocols.
The serum panel consisted of six IAV-negative and 14
IAV-positive samples from five avian species (chicken,
duck, partridge, pheasant, and turkey) that had pre-
viously been confirmed for subtype specificity by HI
assay (Table 1) (4648).
Hemagglutination inhibition
The HI test using chicken erythrocytes was performed on
serum samples treated with receptor-destroying enzyme
(RDE) (Nordic Biolabs) as described in detail elsewhere
(31). H5N2 and H7N7 viruses were used in the HI assay
and were diluted to 8 HA units. The serum was serially
diluted twofold, and duplicate samples were tested in two
separate experiments. Button formation was scored as
evidence of HI, and the serum titers are expressed as the
reciprocal of the highest serum dilution that resulted in
complete inhibition of hemagglutination.
Microneutralization assay
The MN test was evaluated by CPE in cell culture (MN-
CPE) and was performed using twofold serially diluted
heat-inactivated serum and 100 TCID50 of H5N2 or
H7N7 virus according to a protocol modified from the
World Health Organization (WHO) manual (31). Briefly,
Table 1. Geometric mean titer of influenza antibodies in avian sera determined by pseudovirus particle neutralization testing
Serum pp-NT(H5)b
pp-NT(H7)b
Strain Species Description HIa Anhui Hong Kong Indonesia Mongolia Turkey Vietnam Italy
H4N6 SPF chicken Exp. infection 2048       
H5N1 Turkey Exp. infection 32 170 200 110 100 80 80 
H5N1 Turkey Exp. infection 64 40 80 80 60 290 100 
H5N2 Pheasant Field sera 64 90 150 70 200 40 90 
H5N2 Pheasant Field sera 64 120 350 60 90 230 150 
H5N2 Turkey Field sera 64 2060 90  70 50 60 
H5N9 SPF chicken Exp. infection 128 150 110 60 50 40 130 
H6N2 SPF chicken Exp. infection 32       
H7N1 Duck Exp. infection 2048       100
H7N1 Duck Exp. infection 1024       130
H7N3 Turkey Field sera 16       
H7N3 Turkey Field sera 16       
H7N7 SPF chicken Exp. infection 256       40
H9N2 Duck Exp. infection 32       
Neg Turkey Field sera B2       
Neg Turkey Field sera B2       
Neg Turkey Field sera B2       
Neg Partridge Field sera B2       
Neg SPF chicken Field sera B2       
Neg Chicken Field sera B2       
aHI titer using homologous avian influenza A antigen.
b  corresponds to a geometric mean titer of B1:40.
HI, hemagglutination inhibition; SPF, specific pathogen free; pp-NT, pseudovirus particle neutralization test; Exp, experimental.
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a serumvirus mixture was incubated on MDCK cells
and monitored for CPE 7296 h after infection, and the
virus-neutralizing titer was defined as the reciprocal of
the serum dilution required to inhibit virus infectivity by
approximately 80%. Rabbit sera were tested in duplicate
in four independent experiments. For the colorimetric
MN tests, CellTiter96AQuous (Promega Corporation)
or WST-1 (Roche) solution (denoted Col1 and Col2,
respectively) was added to each well 72 h after infection,
as stipulated in the protocols provided by the manu-
facturers. The absorbance was measured at 492 nm for
MN-Col1 and at 405 nm for MN-Col2 in a spectro-
photometer (Labsystems, Multiscan EX). The neutraliz-
ing antibody titer was determined as the reciprocal of
the highest serum dilution that resulted in 80% inhibition
of virus infectivity and was calculated as follows: [(A492
serum  A492 virus control) / A492 virus control)100]
for MN-Col1 and [(A405 serum  A405 virus control) /A405
virus control)100] for MN-Col2.
Pseudovirus particle neutralization test
Performance of the pp-NT has been described previously
(39). In our study, the Anhui, Hong Kong, Indonesia,
Italy, Mongolia, Vietnam, and Turkey pseudoviruses were
incubated with twofold serially diluted heat-inactivated
serum for 1 h at 378C in 5% CO2, and then approximately
5103 293T/17 cells were added to each well. After further
incubation for 48 h, BrightGlo (Promega Corporation)
was added according to the manufacturer’s instructions,
and relative luminescence units (RLUs) were measured in
a luminometer (GloMax† 96 Microplate Luminometer,
Promega Corporation). The inhibitory effect of the
serum on pseudovirus infectivity was calculated by fitt-
ing the percentage of inhibition of RLU values [(RLU
pseudovirus control  RLU serum) / (RLU pseudovirus
control)100] (49) to a sigmoid doseresponse curve with
variable slope by use of GraphPad Prism 6.0 software, as
previously described (34). The virus-neutralizing titer was
defined as the reciprocal of the serum dilution required to
inhibit pseudotype infectivity by 80%, and such titers are
presented as the geometric mean. Rabbit serum samples
were tested in duplicate in three or more independent
experiments, and the avian serum samples were tested in
duplicate.
Results and discussion
Ever since the first reports of HPAI virus in humans
appeared in the literature (50, 51), the surveillance of wild
birds has become a key element in predicting and
preventing outbreaks. In the European Union, it is
compulsory to report the data obtained in this context,
which cover not only wild birds that are sick or dead but
also those that are healthy. Accordingly, there is a
continuous need for safer and less labor-intensive ser-
ological methods to help evaluate serum samples col-
lected from both wild and domestic fowl.
Considering performance, we initially compared the
different pp-NTs with standard methods such as HI
and MN tests using serum from infected rabbits (Fig. 1).
Each assay detecting anti-H5 or anti-H7 antibodies was
evaluated using rabbit serum samples collected before
infection of the animals (negative control), after infection
with LPAI of subtype H5N2, or after infection with
H7N7 virus (Fig. 1).
Although the HI assay does not detect specific virus-
neutralizing antibodies, we included it in our study because
it is one of the reference diagnostic methods recommended
by the WHO for detection of IAVantibodies in animal sera
(31). Homologous serum with titers of 160 and 640
inhibited hemagglutination of chicken erythrocytes by
H5N2 (Fig. 1A) and H7N7 (Fig. 1B) viruses, respectively.
When testing heterologous serum, cross-inhibition was
observed in the HI assay based on the H5N2 virus
(geometric mean titer 20, Fig. 1A) but not in HI based
on H7N7 (Fig. 1B). MN testing is evaluated by visual
detection of CPE in cell culture and is commonly used to
detect IAV-neutralizing antibodies, and, as mentioned for
the HI assay, it is recommended as a reference method by
the WHO (31). In the traditional MN (MN-CPE), we
found that the H5N2-positive serum had a geometric mean
titer of 40, which is similar to the titers observedwhen using
H5 MN tests based on detection of viable cells by
colorimetric methods (Fig. 1A): 320 for MN-Col1 and
160 for MN-Col2. In good agreement with HI, MN-Col2
has been shown to be a reliable technique for measuring
neutralizing antibodies in human serum samples before
and after immunization with trivalent inactivated influen-
za vaccine (52). MN-Col1 has also been used to comple-
ment CPE readout and to determine antiviral activity (53).
When we applied the corresponding H7 MN test (Fig. 1B),
the homologous serum had a titer of 260 in MN-CPE,
whereas the MN-Col1 and MN-Col2 assays were more
sensitive, that is, they could detect virus-specific antibodies
at considerably higher serum dilutions (titers 7240 and
3230, respectively) (Fig. 1B). Notably, cross-neutralization
with heterologous serum was observed in MN-Col1 and
MN-Col2 assays based on H7 (geometric mean titers 160
and 110, respectively) (Fig. 1B). Negative control sera were
negative in all MN assays, except in the MN-Col2(H7)
assay where the negative control sera diluted 1:80 was
recorded as positive (data not shown).
Tests based on the neutralization of IAV pseudoviruses
have been applied as an alternative to the MN and HI
tests and have been evaluated extensively over the past
few years; this has been done using serum predominantly
obtained from patients (33, 34, 54, 55) but also from birds
38, 56). In our study, all six pp-NT(H5)s based on HPAI
HA subtypes clearly detected the LPAI H5N2-positive
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rabbit serum with geometric mean titers ranging from 150
to 5890 (Fig. 1A). The Anhui, Indonesia, and Mongolia
pseudoviruses had comparable titers of 350, 150, and
440, respectively, whereas the pp-NT(H5)s based on the
Hong Kong, Turkey, and Vietnam pseudoviruses resulted
in slightly higher geometric mean titers of 5890, 720 and
1470 (Fig. 1A). Heterologous serum was able to neutra-
lize the Anhui and Turkey pseudoviruses at low titers (50
and 70, respectively) (Fig. 1A). Cross-neutralization was
also observed in the pp-NT(H5) based on the Hong Kong
pseudovirus (titer 460; Fig. 1A). All the negative control
sera were negative in all ppNT(H5) and ppNT(H7) assays
with the exception of Hong Kong, where control serum
reacted at dilutions ranging from 1:60 to 1:480 when
inhibition of 80% was set as the cutoff (data not shown).
In light of the unspecific reaction in the Hong Kong
pp-NT(H5), it was of interest to determine whether this
feature would also be observed in serum from other
species. To address that issue, we evaluated the Hong
Kong pp-NT(H5) by using 23 IAV H5-negative serum
samples collected from five mallards that had previously
been confirmed to be H5 seronegative by ELISA and HI
assessment (24). None of the serum samples were found
to react in the assay at a serum dilution of 1:40 and an
inhibitory concentration of 50% (data not shown), which
indicates that the unspecific reactions in the assay were
due to the species origin of the serum sample rather than
to the assay itself.
It was recently shown that sera from chickens vaccinated
with LPAI H7N1 effectively neutralized H7 pseudoviruses
(38). Moreover, our pp-NT(H7) detected homologous
serum at a titer of 1,000, and no cross-neutralization was
observed when this test was used to analyze heterologous
serum (Fig. 1B).
Our final experiments were conducted to evaluate the
performances of the various pp-NTs by using a panel of
avian sera (Table 1). The IAV subtype serospecificity of
these serum samples had previously been confirmed by
Fig. 1. Comparison of different antibody detection assays using serum from rabbits infected with H5 and H7 influenza strains.
Serological methods detecting antibodies against H5 (A) and H7 (B) viruses were evaluated using serum from rabbits infected with
LPAI H5N2 or H7N7 virus. The pp-NTs were performed using six different HPAI H5 subtypes (pp-NT(H5)) and one H7 subtype (pp-
NT(H7)). The results of virus neutralization tests (VNT) were determined by either CPE (MN-CPE) or colorimetric (MN-Col1 and
MN-Col2) assays. Bars represent the reciprocal of the geometric mean antibody titer from two or more independent experiments that
inhibited virus or pseudovirus infectivity by 80%.
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HI assay (46), and the HI titers are presented in Table 1.
The pp-NT(H5)s based on Anhui, Hong Kong, Mongolia,
Turkey, and Vietnam performed as well as the HI assays,
recognizing all positive and negative serum samples. In
some cases, these pp-NT(H5)s actually performed even
better in that they detected serum at higher dilutions
compared to the HI tests (Table 1). However, pp-NT(H5)
based on Indonesia failed to classify one serum sample
as positive; this sample had a HI titer of 64 and was
collected from a turkey naturally infected with H5N2. No
false positives were observed in the Hong Kong pp-NT,
again pinpointing a problem with specificity when using
serum from rabbits.
The pp-NT(H7) failed to recognize two serum samples,
both of which were collected in the field from H7N3-
infected turkeys (Table 1). These two samples tested
positive with a HI titer of 16, which is close to the detection
limit of the HI assay. Molesti et al. (38) noted the exact
same phenomenon in several HI-positive birds that had
been naturally infected with H7N3. A possible explana-
tion for these findings is that the antibodies that were
present in the investigated fowl could only inhibit hemag-
glutination, that is, they could not neutralize pseudotyped
virus. Furthermore, it should be noted that the H7N1
and H7N7 seropositive samples obtained from experimen-
tally infected ducks and chicken also had low pp-NT(H7)
titers (100, 130, and 40) compared to the corresponding
HI titers (2048, 1024, and 256), indicating that titers
determined by the pp-NT(H7) are not consistently higher
than HI titers.
Today, serological methods such as ELISA and the HI
assay are utilized in combination with the detection of
nucleic acid to maintain and confirm our knowledge of
currently circulating IAV strains. Although the MN-CPE
seems to be the most specific and consistent method
evaluated here, the present results substantiate the promise
of pp-NTs as a sensitive serological tool for global sur-
veillance of wild birds.
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